Your browser doesn't support javascript.
loading
CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune-related bowel disease.
Feng, Rui; Xu, Ping Ping; Chen, Bai Li; Mao, Ren; Zhang, Sheng Hong; Qiu, Yun; Zeng, Zhi Rong; Chen, Min Hu; He, Yao.
Afiliación
  • Feng R; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Xu PP; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Chen BL; Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, China.
  • Mao R; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Zhang SH; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Qiu Y; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Zeng ZR; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Chen MH; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • He Y; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
J Dig Dis ; 21(2): 98-103, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31916702
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Talidomida / Polimorfismo de Longitud del Fragmento de Restricción / Citocromo P-450 CYP2C19 / Variantes Farmacogenómicas / Inmunosupresores / Enfermedades Intestinales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Dig Dis Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Talidomida / Polimorfismo de Longitud del Fragmento de Restricción / Citocromo P-450 CYP2C19 / Variantes Farmacogenómicas / Inmunosupresores / Enfermedades Intestinales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Dig Dis Año: 2020 Tipo del documento: Article País de afiliación: China